{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:53:30Z","timestamp":1781733210329,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>As yet, there is no functional focal reverser for the adverse effects of cosmetic botulinum toxin injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The authors report the first Phase 1 study in human subjects of local administration of an anticholinesterase for reversing muscle weakness, which may result from these neurotoxin-induced complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>An anticholinesterase, or cholinesterase inhibitor, indicated for reversal of neuromuscular blockage in anesthesia, was injected into the same 5 injection sites as were used for the cosmetic onabotulinum toxinA, glabellar treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In most patients treated with the reversal agent under investigation, there was a notable recovery of cosmetic blockade; no subject treated with placebo demonstrated a reversal response. Evidence of reversal became evident within the first 15 minutes after injection of the study drug, with no major or persistent adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Proof of concept, feasibility, and safety of local neuromodulator reversal are now shown; however, further studies are required to optimize dosage, distribution, and formulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004986","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:00:36Z","timestamp":1769608836000},"page":"576-582","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Proof of Concept, Feasibility, and Safety of Local Anticholinesterase Treatment for Neuromodulator-Induced Facial Muscle Paralysis"],"prefix":"10.1097","volume":"52","author":[{"given":"Steve","family":"Yoelin","sequence":"first","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sera","family":"Pot","sequence":"additional","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Tom","sequence":"additional","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Lam","sequence":"additional","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Kalanski","sequence":"additional","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Harrington","sequence":"additional","affiliation":[{"name":"Steve Yoelin, MD and Medical Associates, Inc., Newport Beach, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer B.","family":"Shah","sequence":"additional","affiliation":[{"name":"Del Nova, Inc., Highland Park (Greater Chicago), Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Carruthers","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gardner","sequence":"additional","affiliation":[{"name":"Del Nova, Inc., Highland Park (Greater Chicago), Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"R1-20260617","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/CCID.S358573","article-title":"Factors associated with likelihood to undergo cosmetic surgical procedures among young adults in the United States: a narrative review","volume":"15","author":"Pearlman","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R2-20260617","first-page":"e1","article-title":"Management of ptosis","volume":"9","author":"King","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"R3-20260617","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00266-020-02027-z","article-title":"Adverse events associated with Botox as reported in a Food and Drug Administration database","volume":"45","author":"Ahsanuddin","year":"2021","journal-title":"Aesthet Plast Surg"},{"key":"R4-20260617","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5114\/ada.2019.82795","article-title":"The whole truth about botulinum toxin\u2014a review","volume":"37","author":"Witmanowski","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"R5-20260617","first-page":"13","article-title":"Complications of Botulinum Toxin A: A Comprehensive Review","volume":"1","author":"Dayan","year":"2018","journal-title":"Scholarly Journal of Otolaryngology"},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","article-title":"Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation","volume":"296","author":"Chertow","year":"2006","journal-title":"JAMA"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"e10659","DOI":"10.1097\/MD.0000000000010659","article-title":"Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)","volume":"97","author":"Bai","year":"2018","journal-title":"Medicine"},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/toxins11090528","article-title":"Antibodies and vaccines against botulinum toxins: available measures and novel approaches","volume":"11","author":"Rasetti-Escargueil","year":"2019","journal-title":"Toxins"},{"key":"R12-20260617","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.NAJ.0000656308.84951.e5","article-title":"The medical treatment of botulism","volume":"120","author":"Scruth","year":"2020","journal-title":"Am J Nurs"},{"key":"R14-20260617","first-page":"164","article-title":"Anticholinesterases and anticholinergic drugs","volume":"4","author":"Nair","year":"2004","journal-title":"Continuing Educ Anaesth Crit Care Pain"},{"key":"R16-20260617","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/TCRM.S323387","article-title":"Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review","volume":"17","author":"Ruangritchankul","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/14764172.2010.514920","article-title":"A validated facial grading scale: the future of facial ageing measurement tools?","volume":"12","author":"Carruthers","year":"2010","journal-title":"J Cosmet Laser Ther"},{"key":"R20-20260617","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/toxins14110772","article-title":"Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles","volume":"14","author":"Kaya Keles","year":"2022","journal-title":"Toxins"},{"key":"R21-20260617","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fphar.2016.00029","article-title":"Botulinum toxin treatment for limb spasticity in childhood cerebral palsy","volume":"7","author":"Pavone","year":"2016","journal-title":"Front Pharmacol"},{"key":"R22-20260617","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/s41433-021-01547-5","article-title":"A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options","volume":"35","author":"Bacharach","year":"2021","journal-title":"Eye (Lond)"},{"key":"R23-20260617","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5624\/isd.2020.50.1.15","article-title":"Accuracy and reliability of 2-dimensional photography versus 3-dimensional soft tissue imaging","volume":"50","author":"Ayaz","year":"2020","journal-title":"Imaging Sci Dent"},{"key":"R24-20260617","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1874210601812010061","article-title":"Comparison of 3D scanning versus 2D photography for the identification of facial soft-tissue landmarks","volume":"12","author":"Zogheib","year":"2018","journal-title":"Open Dent J"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:02:12Z","timestamp":1781730132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004986","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}